These results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two aid the idea of focusing on ACKR3 as a singular strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-similar Conditions. In reaction to this https://damienm516hxm1.blogvivi.com/profile